Interpharm Holdings (OTCPK:IPAH) - Stock Price, News & Analysis

IPAH Stock Overview

Develops, manufactures, and markets generic prescription strength and over-the-counter pharmaceuticals. More details

IPAH fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Shares are highly illiquid

Does not have a meaningful market cap ($7K)

Latest financial reports are more than a year old

Interpharm Holdings, Inc. Competitors

Lucy Scientific Discovery

OTCPK:LSDI.F

US$8.8k

Hero Technologies

OTCPK:HENC

US$563.0

Item 9 Labs

OTCPK:INLB

US$701.0

CBD Life Sciences

OTCPK:CBDL

US$1.4m

Price History & Performance

Summary of all time highs, changes and price drops for Interpharm Holdings
Historical stock prices
Current Share Price	US$0.0001
52 Week High	US$0.0001
52 Week Low	US$0.000001
Beta	0
11 Month Change	0%
3 Month Change	n/a
1 Year Change	n/a
33 Year Change	0%
5 Year Change	9,900.00%
Change since IPO	-100.00%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	IPAH	US Pharmaceuticals	US Market
7D	0%	2.6%	0.5%
1Y	n/a	13.1%	30.7%

Return vs Industry: Insufficient data to determine how IPAH performed against the US Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how IPAH performed against the US Market.

Price Volatility

Is IPAH's price volatile compared to industry and market?
IPAH volatility
IPAH Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	9.9%
Market Average Movement	6.3%
10% most volatile stocks in US Market	16.3%
10% least volatile stocks in US Market	3.1%

Stable Share Price: IPAH has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine IPAH's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1984	n/a	n/a	n/a

Interpharm Holdings, Inc. develops, manufactures, and markets generic prescription strength and over-the-counter pharmaceuticals. The company supplies its medicines to major retailers, wholesalers, managed care organizations, and national distributors. The company was founded in 1984 and is based in Hauppauge, New York.

Interpharm Holdings, Inc. Fundamentals Summary

How do Interpharm Holdings's earnings and revenue compare to its market cap?
IPAH fundamental statistics
Market cap	US$6.67k
Earnings (TTM)	-US$33.69m
Revenue (TTM)	US$69.21m

0.0x

P/S Ratio

0.0x

P/E Ratio

Is IPAH overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
IPAH income statement (TTM)
Revenue	US$69.21m
Cost of Revenue	US$57.21m
Gross Profit	US$12.00m
Other Expenses	US$45.69m
Earnings	-US$33.69m

Last Reported Earnings

Dec 31, 2007

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did IPAH perform over the long term?

See historical performance and comparison